Drugs Made In America Acquisition II Corp. (DMIIR) is a publicly traded company in the Financial Services — Financial - Conglomerates industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $0.07, DMIIR trades at a P/E of 0.40 and an ROE of 2.66%. Market capitalisation stands at $5M.
Balance sheet quality for DMIIR: current ratio of 0.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is below average: free cash flow of -$1.0M represents -24% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Price
| Price | $0.07 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 0.40 |
| Price / Book | 0.01 |
| EV / EBITDA | -5.24 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 2.66% |
| Return on Invested Capital | -0.28% |
| Return on Assets | 2.53% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.34 |
What to look at in Financial Services
Asset managers, brokers, fintech, exchanges. They are not banks — look at AUM, fees and FCF quality.
- 5y revenue growth — Without growth, there is no long-term value creation
- Operating margin — Good asset managers have >30% margins thanks to scalability
- ROE — Quality financial services have a consistent ROE >15%
- FCF / Net Income — Earnings quality — >90% expected in capital-light businesses
- Debt / Equity — Fintech and brokers with high D/E are time bombs in crises
- P/E vs own 5y — Asset managers have stable multiples in well-known ranges
- Dividend yield + buybacks — These businesses return a lot of capital — look at total yield (div + buybacks)
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| DMIIR | Drugs Made In America Acquisition II Corp. | $5M | 0.40 | 0.01 | 2.7% |
| PWF-PZ.TO | Power Financial Corporation | $19.6B | |||
| 0RH1.L | Kinnevik AB | $16.6B | 0.65 | -9.3% | |
| FRHC | Freedom Holding Corp. | $10.1B | 65.13 | 6.68 | 11.0% |
| BIPH | Brookfield Infrastructure Finance ULC 5 % Notes 2021-24.05.81 Global | $5.7B | 24.01 | 1.38 | 6.0% |
| 0OPN.L | Compagnie de l'Odet | $5.5B | |||
| HTH | Hilltop Holdings Inc. | $2.2B | 14.43 | 1.06 | 7.5% |
Price Performance
| 1 month | -10.39% |
| 3 months | -11.56% |
| Year-to-date | -51.93% |
52-Week Range
| 52-week High | $0.17 |
| 52-week Low | $0.06 |
| Avg Volume (90d) | 12K |
Explore sector: Financial Services · Financial - Conglomerates
More sections of DMIIR: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks